Other researchers have proposed that hnRNPA2B1 can inhibit the growth of ovarian cancer cells, reduce the mobility of ovarian cancer cells in vitro, and hinder the formation of xenograft tumors in vivo. The gene discussed is HNRNPA2B1; the disease is ovarian carcinoma.